Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC
- Type
- Retraction
- Notice date
- 7/31/2023 0:00
- Journal
- Oncogene
- Publisher
- Springer - Nature Publishing Group
- Notice DOI
- 10.1038/s41388-023-02790-8
- Original paper DOI
- 10.1038/s41388-021-02103-x
Reasons
- Concerns/Issues about Data
- Duplication of/in Image
- Investigation by Journal/Publisher
- Unreliable Results and/or Conclusions